Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > How could Mackie have sold this to their clients
View:
Post by SPCEO1 on Feb 02, 2021 1:50pm

How could Mackie have sold this to their clients

if they really only believe there is a 10% chance of success in NASH?

None of this adds up.  The foolishness of it all is hard to take on all fronts.
Comment by jfm1330 on Feb 02, 2021 2:08pm
Skipping a lot of posts here since it is very hard to read. It's a whinning festival with no end. That being said SPCEO, if you put 75% chance of success in NASH and apply the Mackie analyst numbers to it what would be the share price? And if you are confident in oncology, how much do you add to that??? What I am trying to say is what is the potential for the SP of Thera in the next five ...more  
Comment by SPCEO1 on Feb 02, 2021 2:12pm
I agree that the upside remains huge but the debacle of this offering, with new pieces of it showing up most every day, cannot be overlooked. But I may take a longer break than Scarlett did, so you may get a break from my righteous indignation (which you refer to as whining).
Comment by qwerty22 on Feb 02, 2021 2:57pm
I'm enjoying(?) your whining analysis, there content as well as anger, keep going.
Comment by qwerty22 on Feb 02, 2021 2:58pm
eviscerating analysts, it's my new favorite sport!
Comment by jfm1330 on Feb 02, 2021 3:07pm
The whining aspect, and you are not alone doing it here, is about the repetition, ad nauseam repetition. I understand your frustration, I bought back two days before the financing at 3.70$ CAN, and it is now at 2.95$. Do you think I am happy? No I am not. But I am still able to see the position management and BOD were in. You see the analysts reports? Well informed experts. Nobody wants to give ...more  
Comment by scarlet1967 on Feb 02, 2021 3:31pm
Below is Ed Nash recent reportsm MDGL market value 1.7B, Akro market value 1B, ICPT market value 1.2B, THTX market value 214 M???? Not wining just saying.... GLMD Galmed Pharmaceuticals Buy $20.00 402.53% (Upside)  ...more  
Comment by Wino115 on Feb 02, 2021 4:36pm
I like your description of what the market wants to see -- Hard Facts on Humans (we are coining this today as HFH since it's what we need).  I wasn't sure if you actually wanted a rough estimate of what a 75% probability would be worth or it was a rhetorical question underlining your point,  but from what was  posted earlier it would be something like a value today per share ...more  
Comment by ANALIAS00 on Feb 02, 2021 2:37pm
:o) So funny ...well .... You know what I mean !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities